Back to Journals » Pediatric Health, Medicine and Therapeutics » Volume 16
Stroke as First Presentation of Rheumatic Heart Disease in Pediatric Age Group – a Case Report from Developing Country, Rwanda
Authors Desta TT
, Peace MK, Kayihura J
Received 16 July 2025
Accepted for publication 14 November 2025
Published 19 November 2025 Volume 2025:16 Pages 307—311
DOI https://doi.org/10.2147/PHMT.S553619
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Roosy Aulakh
Temesgen Tsega Desta,1,2 Mugwaneza Kalisa Peace,2 Johnson Kayihura2
1Rwanda Military Referral and Teaching Hospital (RMRTH), Kigali, Rwanda; 2Department of Pediatrics and Child Health, University of Rwanda, Kigali, Rwanda
Correspondence: Temesgen Tsega Desta, Email [email protected]
Background: Rheumatic heart disease (RHD), a chronic consequence of acute rheumatic fever, rarely presents with stroke as an initial manifestation in children. This report shows a rare scenario where ischemic stroke was the first clinical presentation of underlying RHD.
Case Presentation: A 10-year-old boy presented with seizures, hemiplegia, and expressive aphasia. Echocardiography revealed rheumatic mitral valve disease with a vegetation. Neuroimaging showed multifocal cerebral infarctions suggestive of cardioembolism.
Conclusion: This case emphasizes the importance of echocardiographic screening in pediatric patients presenting with stroke, particularly in endemic regions where subclinical RHD may go undiagnosed.
Keywords: rheumatic heart disease, pediatric stroke, cardioembolism, subclinical RHD
Introduction
Rheumatic heart disease (RHD) remains a leading cause of acquired heart disease in children, especially in low- and middle-income countries. It typically results from repeated episodes of acute rheumatic fever (ARF), leading to chronic valvular damage, most commonly affecting the mitral and aortic valves. Although stroke is a recognized complication of RHD, it is rarely the presenting symptom in pediatric patients.
In general, pediatric stroke though less common than adult stroke, represents a significant cause of morbidity and mortality worldwide, with disproportionately higher burden, delayed diagnosis, and limited access to specialized care in low- and middle-income countries, particularly across Africa. Embolic stroke in this setting may arise from intracardiac thrombi or vegetations on damaged valves, even in the absence of overt clinical signs of carditis or ARF.
The pathophysiology involves cardioembolic stroke secondary to valvular damage and atrial fibrillation, both common complications of advanced RHD. Patients may present with sudden-onset neurological deficits such as hemiparesis, facial droop, or speech disturbances, without any prior known history of cardiac symptoms. In such scenarios, echocardiography is a vital diagnostic tool, revealing valvular lesions, chamber enlargement, or evidence of embolic sources. Other investigations include neuroimaging and workup for infective endocarditis if fever or vegetations are present.1–3
Case Presentation
A previously healthy 10-year-old boy presented with a one-week history of altered mentation and abnormal body movements. His illness began with a frontal headache managed symptomatically at a local clinic. Two days later, he developed focal seizures affecting the left upper and lower extremities, lasting approximately three minutes. Though he regained consciousness, his symptoms progressed over the next few days, with recurrent seizures, speech difficulties, and left-sided weakness. He was evaluated at a district hospital, where he received intravenous antibiotics but showed no improvement and was subsequently referred for specialized care.
Examination Findings
On admission, he was hemodynamically stable His Glasgow Coma Scale (GCS) score was 10, and he demonstrated expressive aphasia. A grade 2/6 Holo-systolic murmur was auscultated at the apex. Neurologically, the patient exhibited left-sided hemiplegia (muscle power 1/5), hypertonia, clonus, reduced sensation, and a positive Babinski sign. Pupils were bilaterally equal, round, and reactive to light, with no cranial nerve deficits.
Investigations Summary
Blood Investigations
Full blood count, C-reactive protein and Blood cultures did not indicate evidence of an acute infectious process.
Echocardiography demonstrated markedly dilated left heart chambers, rheumatic changes of the anterior mitral valve leaflet, and moderate to severe mitral regurgitation. A hyper-echoic, oscillating mass measuring 5×6 mm is noted attached to posterior mitral leaflet, suggestive of old vegetation and good ventricular systolic function (Figure 1).
|
Figure 1 (a) Thickening of the tip of anterior mitral leaflet (white arrow). (b) Hyper- echoic mass attached to the posterior mitral leaflet (black arrow). |
Neuroimaging findings included a CT scan showing left frontal and insular cortical hyperdensity with surrounding minimal subcortical hypoattenuation, and an area of relative hyperattenuation in the right middle cerebral artery (MCA) territory (Figure 2). MRI of the brain revealed acute infarction in the right fronto-parietal and insular regions, with subacute infarcts in the left frontal and insular lobes (Figures 3 and 4). The overall impression was multifocal cerebral infarctions, consistent with a cardioembolic source.
|
Figure 2 CT image: Left frontal and insular cortical hyperdensity with surrounding hypodensity (black arrow); and an area of relative hypodensity in the right fronto-parietal area (white arrow). |
Hospital Course
The patient’s seizures were initially managed with diazepam and then controlled with phenytoin, which remains ongoing. Anticoagulation with subcutaneous heparin was initiated and later continued to receive aspirin. Physiotherapy also initiated. Notably, he has shown improvement in motor function of the left limbs and is now able to speak a few words. Later the patient has continued follow up at pediatric neurology and cardiology clinics.
Discussion
This case exemplifies an unusual presentation of pediatric ischemic stroke due to RHD-related cardioembolism. The presence of a mitral valve vegetation and multifocal infarcts in various stages (acute and subacute) strongly support the diagnosis. The absence of classic ARF manifestations such as fever, arthritis, or chorea, and the lack of known prior cardiac disease, reflect how RHD can remain clinically silent until severe complications arise.
The dual-phase infarcts observed on MRI (acute and subacute) suggest recurrent embolic events. Echocardiography was crucial in revealing the underlying pathology. In this patient, the disease likely evolved silently over time (subclinical), only becoming clinically evident after a catastrophic embolic event following superimposed infective endocarditis.
Subclinical RHD—defined as echocardiographic evidence of valvular disease in asymptomatic individuals—is increasingly recognized in endemic areas.2,3 Studies report prevalence up to 10 times higher when systematic echocardiographic screening is used compared to clinical detection alone.2 The only clinical clue in this child was a systolic murmur, emphasizing the need for high suspicion and routine screening in endemic populations.
The multifocal nature of the infarcts indicates ongoing embolic events, likely originating from the mitral vegetation. Prompt recognition and initiation of secondary prophylaxis can prevent recurrence and reduce long-term morbidity.4,5
Limitation
Additional advanced imaging, such as MRI angiography, would have provided further valuable diagnostic evidences.
Conclusion
RHD complicated with infective endocarditis may initially present as ischemic stroke because of embolised vegetation in children, especially in endemic regions where subclinical disease often goes undetected. Echocardiography is essential in the evaluation of pediatric stroke to identify potential cardiac sources. This case underscores the importance of integrating cardiac and neurological assessment in pediatric stroke management and the value of echocardiographic screening in high-risk populations.
Consent for Publication
No institutional approval is required for case report publication. But the child’s parents have provided full, informed, and written consent for the inclusion of case-related information concerning their child in this article submitted for publication.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Reményi B, Wilson N, Steer A, et al. World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease: an evidence-based guideline. Nat Rev Cardiol. 2012;9(5):297–309. doi:10.1038/nrcardio.2012.7
2. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357(5):470–476. doi:10.1056/NEJMoa065085
3. Roberts K, Maguire G, Brown A, et al. Screening for rheumatic heart disease: current approaches and controversies. Curr Cardiol Rep. 2013;15(3):343. doi:10.1007/s11886-012-0343-1
4. Zühlke LJ, Engel ME, Karthikeyan G, et al. Clinical outcomes in children with latent rheumatic heart disease. N Engl J Med. 2021;385(9):826–835. doi:10.1056/NEJMra2104091
5. Beaton A, Okello E, Engelman D, et al. Prevention and control of rheumatic heart disease: a call to action for global health. Lancet. 2016;387(10020):717–726.
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
